Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H22N8O5S2 |
InChIKeyRSINKZJTTORDAJ-UHFFFAOYSA-N |
CAS Registry13616-29-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | - | 25 Feb 2008 | |
Neoplasms | Preclinical | ES | 25 Feb 2008 |